Authors:
Oikonomakos, NG
Skamnaki, VT
Tsitsanou, KE
Gavalas, NG
Johnson, LN
Citation: Ng. Oikonomakos et al., A new allosteric site in glycogen phosphorylase b as a target for drug interactions, STRUCT F D, 8(6), 2000, pp. 575-584
Citation: Vt. Skamnaki et Ng. Oikonomakos, Kinetic characterization of the double mutant R148A/E182S of glycogen phosphorylase kinase catalytic subunit: The role of the activation loop, J PROTEIN C, 19(6), 2000, pp. 499-505
Authors:
Oikonomakos, NG
Schnier, JB
Zographos, SE
Skamnaki, VT
Tsitsanou, KE
Johnson, LN
Citation: Ng. Oikonomakos et al., Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site, J BIOL CHEM, 275(44), 2000, pp. 34566-34573
Authors:
Tsitsanou, KE
Skamnaki, VT
Oikonomakos, NG
Citation: Ke. Tsitsanou et al., Structural basis of the synergistic inhibition of glycogen phosphorylase aby caffeine and a potential antidiabetic drug, ARCH BIOCH, 384(2), 2000, pp. 245-254
Authors:
Tsitsanou, KE
Oikonomakos, NG
Zographos, SE
Skamnaki, VT
Gregoriou, M
Watson, KA
Johnson, LN
Fleet, GWJ
Citation: Ke. Tsitsanou et al., Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure, PROTEIN SCI, 8(4), 1999, pp. 741-749
Authors:
Oikonomakos, NG
Tsitsanou, KE
Zographos, SE
Skamnaki, VT
Goldmann, S
Bischoff, H
Citation: Ng. Oikonomakos et al., Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarboxylate, PROTEIN SCI, 8(10), 1999, pp. 1930-1945